VILINBIOPharmaceuticals
Vilin Bio Med Ltd — Profit & Loss Statement
₹38.10
+0.00%
Vilin Bio Med Ltd Profit & Loss Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 55478.58 |
| Tax Rate For Calcs | 0.28 | 0.30 | 0.25 | 0.25 |
| Normalized EBITDA | 1.14 Cr | 2.60 Cr | 0.76 Cr | 0.81 Cr |
| Net Income From Continuing Operation Net Minority Interest | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.12 Cr |
| Reconciled Depreciation | 0.13 Cr | 0.17 Cr | 0.22 Cr | 0.26 Cr |
| Reconciled Cost Of Revenue | 13.01 Cr | 7.17 Cr | 9.09 Cr | 9.31 Cr |
| EBITDA | 1.14 Cr | 2.60 Cr | 0.76 Cr | 0.83 Cr |
| EBIT | 1.01 Cr | 2.43 Cr | 0.54 Cr | 0.58 Cr |
| Net Interest Income | -0.79 Cr | -0.65 Cr | -0.51 Cr | -0.44 Cr |
| Interest Expense | 0.79 Cr | 0.65 Cr | 0.49 Cr | 0.41 Cr |
| Normalized Income | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.10 Cr |
| Net Income From Continuing And Discontinued Operation | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.12 Cr |
| Total Expenses | 15.12 Cr | 9.91 Cr | 10.67 Cr | 11.14 Cr |
| Diluted NI Availto Com Stockholders | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.12 Cr |
| Net Income Common Stockholders | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.12 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.12 Cr |
| Net Income Including Noncontrolling Interests | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.12 Cr |
| Net Income Continuous Operations | 0.16 Cr | 1.25 Cr | 0.03 Cr | 0.12 Cr |
| Tax Provision | 0.06 Cr | 0.54 Cr | 0.01 Cr | 0.04 Cr |
| Pretax Income | 0.23 Cr | 1.78 Cr | 0.04 Cr | 0.16 Cr |
| Other Non Operating Income Expenses | 0.32 Cr | 0.02 Cr | 42000.00 | 36000.00 |
| Net Non Operating Interest Income Expense | -0.79 Cr | -0.65 Cr | -0.51 Cr | -0.44 Cr |
| Interest Expense Non Operating | 0.79 Cr | 0.65 Cr | 0.49 Cr | 0.41 Cr |
| Operating Income | 0.69 Cr | 2.41 Cr | 0.55 Cr | 0.58 Cr |
| Operating Expense | 2.11 Cr | 2.74 Cr | 1.58 Cr | 1.83 Cr |
| Other Operating Expenses | 1.18 Cr | 1.79 Cr | 0.22 Cr | 0.41 Cr |
| Depreciation And Amortization In Income Statement | 0.13 Cr | 0.17 Cr | 0.22 Cr | 0.26 Cr |
| Depreciation Income Statement | 0.13 Cr | 0.17 Cr | 0.22 Cr | 0.26 Cr |
| Gross Profit | 2.80 Cr | 5.14 Cr | 2.13 Cr | 2.41 Cr |
| Cost Of Revenue | 13.01 Cr | 7.17 Cr | 9.09 Cr | 9.31 Cr |
| Total Revenue | 15.80 Cr | 12.31 Cr | 11.21 Cr | 11.72 Cr |
| Operating Revenue | 15.80 Cr | 12.31 Cr | 11.21 Cr | 11.72 Cr |
| Basic EPS | — | 0.89 | 0.02 | 0.09 |
| Total Unusual Items | — | 0.00 | 0.00 | 0.02 Cr |
| Total Unusual Items Excluding Goodwill | — | 0.00 | 0.00 | 0.02 Cr |
| Diluted Average Shares | — | 1.40 Cr | 1.40 Cr | 1.40 Cr |
| Basic Average Shares | — | 1.40 Cr | 1.40 Cr | 1.40 Cr |
| Diluted EPS | — | 0.89 | 0.02 | 0.09 |
| Special Income Charges | — | 0.00 | 0.00 | 0.02 Cr |
| Net Income Extraordinary | — | — | 0.00 | 0.00 |
| Net Income Discontinuous Operations | — | — | 0.00 | 0.00 |
| Total Other Finance Cost | — | — | 0.01 Cr | 0.03 Cr |
| Selling General And Administration | — | — | 0.14 Cr | 0.11 Cr |
| Selling And Marketing Expense | — | — | 83000.00 | 54000.00 |
| General And Administrative Expense | — | — | 0.13 Cr | 0.10 Cr |
| Other Special Charges | — | — | — | -0.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Vilin Bio Med Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.